Faron Pharmaceuticals
Turku
About Faron Pharmaceuticals
Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $95.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2026)
- Ticker: lse:FARN
- Website: faron.com
- Phone: +35802469515
Industries & Categories
Biopharma, Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/faron-pharmaceuticals-40416 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.